In conclusion, we observed that all four Ameloblastoma patients carried BRAF V600E which maybe the first hit crucial for Ameloblastoma susceptibility, and they all carried a second mutation, even a less deleterious one, which may eventually start the tumorigenesis. The gene discussed is BRAF; the disease is ameloblastoma.